Please Wait

Applying Filters...

Annual Sales of Narbivolol reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Narbivolol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 15 USDMF, 8 CEP/COS, 7 EU WC, 11 KDMF, 9 NDC API, 29 Listed Suppliers, $ API Reference Price

INTERMEDIATES

28 API Suppliers

28 API Suppliers

FINISHED DOSAGE FORMULATIONS

263 FDF Dossiers, 72 FDA Orange Book, 109 Europe, 4 Canada, 30 Australia, 2 South Africa, 46 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 5MG BASE;80MG, TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 2.5MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 4 DKSH, 2 Jai Radhe Sales, 2 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 3 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 13 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 31 Direct Compression, 26 Controlled & Modified Release, 20 Disintegrants & Superdisintegrants, 18 Granulation, 16 Lubricants & Glidants, 15 Thickeners and Stabilizers, 14 Film Formers & Plasticizers, 14 Co-Processed Excipients, 13 Solubilizers, 10 Taste Masking, 8 Parenteral, 7 Emulsifying Agents, 6 API Stability Enhancers, 6 Topical, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 23 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 102 Finished Drug Prices, 5 Annual Reports

MARKET PLACE

24 APIs, 5 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

6 USP, 6 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

5 All

01 1Bystolic

02 4Bystolic/Byvalson

List of Suppliers

Product Main Page

01

Brand Name : Bystolic/Byvalson

Formnext Forum

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Nebivolol HCl

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2017 Revenue in Millions : 614

2016 Revenue in Millions : 641

Growth (%) : -4

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Bystolic/Byvalson

Formnext Forum

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Nebivolol HCl

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 586

2017 Revenue in Millions : 614

Growth (%) : -5%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Bystolic/Byvalson

Formnext Forum

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Nebivolol HCl

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2016 Revenue in Millions : 641

2015 Revenue in Millions : 646

Growth (%) : -1

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Bystolic/Byvalson

Formnext Forum

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2019 Revenue in Millions : 603

2018 Revenue in Millions : 586

Growth (%) : 3

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Bystolic

Formnext Forum

Not Confirmed

Contact us
to update this info